In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OptiBiotix Health Strikes Deal To Take CholBiome Probiotic Into Russia And Kazakhstan

Executive Summary

British probiotic specialist OptiBiotix Health has struck a three-year distribution deal for its CholBiome supplement in Russia and Kazakhstan.

You may also be interested in...



Health And Wellness Launches: Enviromedica, Garden Of Life, Mineralife, Bimble, Chobani, GT, Chomptown, More

Chobani introduces first line of non-dairy, plant-based yogurts; Mineralife in CBD market with MG Labs brand; Silk dairy-alternative line expands with Oat Yeah milk; Garden of Life extends to keto; Aloha protein powder reformulated; Arthrocen joint supplement in US; Chomptown Cookies from pea protein; GT is Good! on protein bars; Bimble bubbles with CBD; Enviromedica innovates in microbiome; and sweet potato and cayenne-infused date nectars from D'Vash.

Beauty Supplements Draw Young Adults, Disease Prevention Attracts All Ages

Most US women ages 18-34 who take a supplement do so for beauty benefits, finds Mintel in a survey. Natural Marketing Institute says with science increasing understanding of nutrients, firms should offer supplements that address symptoms of common conditions consumers are treating with drugs.

Stada Looks To Take Slice Of Growing Probiotics Market With Launch Of Probielle In Germany

Stada Arzneimittel moves into the German probiotics market with four new products under its Probielle brand.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel